Grant: Health System Impact Fellowships - PostDoc Central Canada 2-year
Ottawa Hospital Research Institute
$108,500.00
Applying co-production to enhance Ontario's clinical trial landscape
EF 2022-23
Résumé
Clinical trials are the 'gold standard' of health care evidence. Thus, participation in trials is necessary to improve health care. However, equity-deserving groups are significantly less likely to participate in trials than non-equity-deserving groups. This comes with harms such as variance in standard of care, which may magnify pre-existing health disparities and create health inequities. Co-production and behavioural science can help identify strategies to improve equity, diversity, and inclusion (EDI) in trials. This fellowship will use co-production to improve EDI in multi-site trials in Ontario over three objectives: 1) Describe inequities in trial participation. Clinical Trials Ontario (CTO) has a novel platform ("Stream") that enables ethics review and conduct of multi-site trials from one Research Ethics Board (REB). The Stream database will be analyzed to identify existing questions and develop future questions for EDI. Theory-informed online surveys will quantitatively assess inclusion/exclusion of equity-deserving groups and qualitatively explore determinants of EDI recruitment behaviours. 2) Evaluate EDI in trial recruitment and retention. Using behavioural theory, interviews among patients, trialists, REBs will investigate strategies that support recruitment of equity-deserving groups into trials and equity-deserving groups' barriers and enablers to participating in trials. 3) Co-develop strategies to improve EDI in trial recruitment and retention. A working group of patients, trialists, and REBs will be formed to co-develop a tool(kit) to guide EDI in trials. Behaviour change techniques (BCTs) will be chosen to overcome barriers and enhance enablers in Objective 2; the most relevant BCTs will be encompassed in the tool(kit). A consensus process will inform a final tool(kit) to be housed on CTO's website. Results will help CTO enact province-wide change in trial EDI and meet its priority of engaging patients and the public in trial ethics and conduct.
Programme
Health System Impact Fellowships - PostDoc Central Canada 2-year
Bénéficiaire
Emplacement
Ontario, Canada
Type de bénéficiaire
Other
Type
Grant
Source
CIHR Funding Decisions Database
Tel que publié
Id
484616
Name
Morgan Tamara
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Health Services and Policy Research
Theme2
Health systems / services
Prcname2
Fellowship : Health System Impact Fellowship Post Doctoral Fellows
Projecttitle
Applying co-production to enhance Ontario's clinical trial landscape
Programtype2
Fellowship Programs
Orgnameinp2
Ottawa Hospital Research Institute
Cihramount2
$108,500
Cihrequipment2
$0
Programname2
Health System Impact Fellowships - PostDoc Central Canada 2-year
Keyworddelim
Behavioural Psychology; Clinical Trial Ethics; Health Equity; Implementation Science
Abstract
Clinical trials are the 'gold standard' of health care evidence. Thus, participation in trials is necessary to improve health care. However, equity-deserving groups are significantly less likely to participate in trials than non-equity-deserving groups. This comes with harms such as variance in standard of care, which may magnify pre-existing health disparities and create health inequities. Co-production and behavioural science can help identify strategies to improve equity, diversity, and inclusion (EDI) in trials. This fellowship will use co-production to improve EDI in multi-site trials in Ontario over three objectives: 1) Describe inequities in trial participation. Clinical Trials Ontario (CTO) has a novel platform ("Stream") that enables ethics review and conduct of multi-site trials from one Research Ethics Board (REB). The Stream database will be analyzed to identify existing questions and develop future questions for EDI. Theory-informed online surveys will quantitatively assess inclusion/exclusion of equity-deserving groups and qualitatively explore determinants of EDI recruitment behaviours. 2) Evaluate EDI in trial recruitment and retention. Using behavioural theory, interviews among patients, trialists, REBs will investigate strategies that support recruitment of equity-deserving groups into trials and equity-deserving groups' barriers and enablers to participating in trials. 3) Co-develop strategies to improve EDI in trial recruitment and retention. A working group of patients, trialists, and REBs will be formed to co-develop a tool(kit) to guide EDI in trials. Behaviour change techniques (BCTs) will be chosen to overcome barriers and enhance enablers in Objective 2; the most relevant BCTs will be encompassed in the tool(kit). A consensus process will inform a final tool(kit) to be housed on CTO's website. Results will help CTO enact province-wide change in trial EDI and meet its priority of engaging patients and the public in trial ethics and conduct.
Competitiondate
202303
Approvedterm2
2 yrs 0 mth
Pinamesdelim
Morgan, Tamara
Approvedterm
2 ans 0 mois
Cihrcontribution2
IPPH~ $108,500~ $0~